{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "POSTPOST", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -0.32786855, "regularMarketPrice": 6.08, "exchange": "PAR", "shortName": "ACTICOR BIOTECH", "longName": "Acticor Biotech SAS", "messageBoardId": "finmb_283354646", "exchangeTimezoneName": "Europe/Paris", "market": "fr_market", "regularMarketTime": 1683900706, "regularMarketDayHigh": 6.18, "regularMarketDayRange": "6.0 - 6.18", "regularMarketDayLow": 6.0, "regularMarketVolume": 879, "regularMarketPreviousClose": 6.1, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Paris", "financialCurrency": "EUR", "regularMarketOpen": 6.1, "averageDailyVolume3Month": 3977, "averageDailyVolume10Day": 2597, "fiftyTwoWeekLowChange": 0.98, "fiftyTwoWeekLowChangePercent": 0.19215687, "fiftyTwoWeekRange": "5.1 - 11.0", "fiftyTwoWeekHighChange": -4.92, "fiftyTwoWeekHighChangePercent": -0.44727275, "fiftyTwoWeekLow": 5.1, "fiftyTwoWeekHigh": 11.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.45, "sharesOutstanding": 12305000, "bookValue": -0.213, "fiftyDayAverage": 6.3568, "fiftyDayAverageChange": -0.27680016, "fiftyDayAverageChangePercent": -0.043543946, "twoHundredDayAverage": 6.63065, "twoHundredDayAverageChange": -0.5506501, "twoHundredDayAverageChangePercent": -0.083046176, "marketCap": 76020064, "priceToBook": -28.544601, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.0 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1635753600000, "priceHint": 2, "regularMarketChange": -0.01999998, "symbol": "ALACT.PA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "HOpital Bichat", "address2": "INSERM U1148 46 rue Henri Huchard", "city": "Paris", "zip": "75018", "country": "France", "phone": "33 6 76 23 38 13", "website": "https://www.acticor-biotech.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Acticor Biotech SAS operates as a clinical stage biopharmaceutical company that develops drugs for the treatment for acute thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets platelet glycoprotein VI. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Gilles  Avenard M.D.", "age": 71, "title": "Founder, CEO & Director", "yearBorn": 1951, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Philippe  Billiald Ph.D., Pharm.D.", "title": "Scientific Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Martine  Jandrot-Perrus M.D., Ph.D.", "title": "Scientific Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eric  Cohen", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sophie  Lebel-Binay Ph.D.", "age": 54, "title": "Deputy CEO, Chief Scientific Officer & GM", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Aymeric  Humblot", "title": "Head of Fin. & Admin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yannick  Pletan M.D., M.Sc.", "age": 69, "title": "Deputy CEO, GM & Chief Medical Officer", "yearBorn": 1953, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Laurie  Jullien", "title": "Head of Regulatory Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kristell  Lebozec Ph.D.", "title": "Head of Pharmaceutical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Victoria  Rutman Pharm.D.", "title": "Head of Quality Assurance", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}